Repositorio Dspace

Intraocular implants loaded with A3R agonist rescue retinal ganglion cells from ischemic damage

Mostrar el registro sencillo del ítem

dc.contributor.author Boia, Raquel
dc.contributor.author Dias, Paul-AN
dc.contributor.author Galindo-Romero, Caridad
dc.contributor.author Ferreira, Hugo-D
dc.contributor.author Aires, Ines-D
dc.contributor.author Vidal-Sanz, Manuel
dc.contributor.author Agudo-Barriuso, Marta
dc.contributor.author Bernardes, Rui
dc.contributor.author Santos, Paulo-F
dc.contributor.author de-Sousa, Herminio-C
dc.contributor.author Ambrosio, Antonio-Francisco
dc.contributor.author Braga, Mara-EM
dc.contributor.author Santiago, Ana-Raquel
dc.date.accessioned 2025-12-03T11:15:56Z
dc.date.available 2025-12-03T11:15:56Z
dc.date.issued 2022-03
dc.identifier.citation Boia R, Dias PAN, Galindo-Romero C, Ferreira H, Aires ID, Vidal-Sanz M, et al. Intraocular implants loaded with A3R agonist rescue retinal ganglion cells from ischemic damage. Journal of Controlled Release. marzo de 2022;343:469-81.
dc.identifier.issn 0168-3659
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/23033
dc.description.abstract Retinal ganglion cell (RGC) loss underlies several conditions which give rise to significant visual compromise, including glaucoma and ischaemic optic neuropathies. Neuroprotection of RGCs is a clinical well-defined unmet need in these diseases, and adenosine A(3) receptor (A(3)R) activation emerges as a therapeutic pharmacological approach to protect RGCs. A porous biodegradable intraocular implant loaded with 2-Cl-IB-MECA (selective A(3)R agonist) was used as a strategy to protect RGCs. Drug-loaded PCL implants released 2-Cl-IB-MECA for an extended period and the released 2-Cl-IB-MECA limited glutamate-evoked calcium (Ca(2+)) rise in RGCs. Retinal thinning due to transient ischemia was not prevented by 2-Cl-IB-MECA-PCL implant. However, 2-Cl-IB-MECA-PCL implants decreased retinal cell death, promoted the survival of RGCs, preserved optic nerve structure and anterograde axonal transport. We further demonstrated that 2-Cl-IB-MECA-loaded PCL implants were able to enhance RGC function that was compromised by transient ischemia. Taking into consideration the beneficial effects afforded by 2-Cl-IB-MECA released from the PCL implant, this can be envisaged a good therapeutic strategy to protect RGCs.
dc.language.iso eng
dc.publisher ELSEVIER
dc.rights Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional 
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0 * 
dc.subject.mesh Adenosine A3 Receptor Agonists/pharmacology
dc.subject.mesh Humans
dc.subject.mesh Ischemia/drug therapy
dc.subject.mesh Receptor, Adenosine A3/metabolism
dc.subject.mesh Retina/metabolism
dc.subject.mesh Retinal Ganglion Cells
dc.title Intraocular implants loaded with A3R agonist rescue retinal ganglion cells from ischemic damage
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 35131370
dc.relation.publisherversion https://linkinghub.elsevier.com/retrieve/pii/S016836592200075X
dc.identifier.doi 10.1016/j.jconrel.2022.02.001
dc.journal.title Journal of Controlled Release
dc.identifier.essn 1873-4995


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional  Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional 

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta